Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Towa Pharmaceutical Co ( (JP:4553) ) has provided an announcement.
Towa Pharmaceutical Co., Ltd. announced a revision of its dividend forecast for the fiscal year ending March 31, 2025, increasing the year-end dividend from 30 yen per share to 40 yen per share, resulting in a total annual dividend of 70 yen per share. This decision reflects the company’s strong financial performance and progress toward its medium-term business plan objectives, which may positively impact stakeholders by potentially increasing shareholder value.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd. is a company based in Kadoma, Osaka, that operates in the pharmaceutical industry. It focuses on manufacturing and distributing generic drugs and is committed to enhancing its research and development capabilities to support future growth.
YTD Price Performance: -8.73%
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $936.4M
See more data about 4553 stock on TipRanks’ Stock Analysis page.
